120 related articles for article (PubMed ID: 9268157)
1. A peptide encoding a B-cell epitope from the N-terminus of the capsid protein L2 of bovine papillomavirus-4 prevents disease.
Campo MS; O'Neil BW; Grindlay GJ; Curtis F; Knowles G; Chandrachud L
Virology; 1997 Aug; 234(2):261-6. PubMed ID: 9268157
[TBL] [Abstract][Full Text] [Related]
2. Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4.
Chandrachud LM; Grindlay GJ; McGarvie GM; O'Neil BW; Wagner ER; Jarrett WF; Campo MS
Virology; 1995 Aug; 211(1):204-8. PubMed ID: 7544045
[TBL] [Abstract][Full Text] [Related]
3. Linear B-cell epitopes in the N-terminus of L2 of bovine papillomavirus type 4.
Knowles G; Grindlay GJ; Campo MS; Chandrachud LM; O'Neil BW
Res Vet Sci; 1997; 62(3):289-91. PubMed ID: 9300551
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies.
Gaukroger JM; Chandrachud LM; O'Neil BW; Grindlay GJ; Knowles G; Campo MS
J Gen Virol; 1996 Jul; 77 ( Pt 7)():1577-83. PubMed ID: 8758002
[TBL] [Abstract][Full Text] [Related]
5. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization.
Kirnbauer R; Chandrachud LM; O'Neil BW; Wagner ER; Grindlay GJ; Armstrong A; McGarvie GM; Schiller JT; Lowy DR; Campo MS
Virology; 1996 May; 219(1):37-44. PubMed ID: 8623552
[TBL] [Abstract][Full Text] [Related]
6. Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes.
Roden RB; Yutzy WH; Fallon R; Inglis S; Lowy DR; Schiller JT
Virology; 2000 May; 270(2):254-7. PubMed ID: 10792983
[TBL] [Abstract][Full Text] [Related]
7. Humoral immune response to the E7 protein of bovine papillomavirus type 4 and identification of B-cell epitopes.
Chandrachud LM; O'Neil BW; Jarrett WF; Grindlay GJ; McGarvie GM; Campo MS
Virology; 1994 Apr; 200(1):98-104. PubMed ID: 7510442
[TBL] [Abstract][Full Text] [Related]
8. Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway.
Peng S; Frazer IH; Fernando GJ; Zhou J
Virology; 1998 Jan; 240(1):147-57. PubMed ID: 9448699
[TBL] [Abstract][Full Text] [Related]
9. Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes.
Palmer KE; Benko A; Doucette SA; Cameron TI; Foster T; Hanley KM; McCormick AA; McCulloch M; Pogue GP; Smith ML; Christensen ND
Vaccine; 2006 Jun; 24(26):5516-25. PubMed ID: 16725236
[TBL] [Abstract][Full Text] [Related]
10. Development of a vaccine marker technology: display of B cell epitopes on the surface of recombinant polyomavirus-like pentamers and capsoids induces peptide-specific antibodies in piglets after vaccination.
Neugebauer M; Walders B; Brinkman M; Ruehland C; Schumacher T; Bertling WM; Geuther E; Reiser CO; Reichel C; Strich S; Hess J
Biotechnol J; 2006 Dec; 1(12):1435-46. PubMed ID: 17109492
[TBL] [Abstract][Full Text] [Related]
11. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
12. Studies on vaccination against papillomaviruses: the immunity after infection and vaccination with bovine papillomaviruses of different types.
Jarrett WF; O'Neil BW; Gaukroger JM; Smith KT; Laird HM; Campo MS
Vet Rec; 1990 May; 126(19):473-5. PubMed ID: 2161579
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
14. Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions.
Liu WJ; Gissmann L; Sun XY; Kanjanahaluethai A; Müller M; Doorbar J; Zhou J
Virology; 1997 Jan; 227(2):474-83. PubMed ID: 9018146
[TBL] [Abstract][Full Text] [Related]
15. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
[TBL] [Abstract][Full Text] [Related]
16. Bovine serological response to a recombinant BPV-1 major capsid protein vaccine.
Jin XW; Cowsert L; Marshall D; Reed D; Pilacinski W; Lim LY; Jenson AB
Intervirology; 1990; 31(6):345-54. PubMed ID: 2177743
[TBL] [Abstract][Full Text] [Related]
17. Mapping of linear B cell epitopes on capsid proteins of bovine papillomavirus: identification of three external type-restricted epitopes.
Cason J; Kambo PK; Jewers RJ; Chrystie IL; Best JM
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2669-77. PubMed ID: 8277272
[TBL] [Abstract][Full Text] [Related]
18. Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos.
Zamorano P; Wigdorovitz A; Chaher MT; Fernandez FM; Carrillo C; Marcovecchio FE; Sadir AM; Borca MV
Virology; 1994 Jun; 201(2):383-7. PubMed ID: 8184548
[TBL] [Abstract][Full Text] [Related]
19. Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20 -- 38) peptide displayed on bacterial thioredoxin.
Rubio I; Bolchi A; Moretto N; Canali E; Gissmann L; Tommasino M; Müller M; Ottonello S
Vaccine; 2009 Mar; 27(13):1949-56. PubMed ID: 19368776
[TBL] [Abstract][Full Text] [Related]
20. Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16 VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice.
Revaz V; Benyacoub J; Kast WM; Schiller JT; De Grandi P; Nardelli-Haefliger D
Virology; 2001 Jan; 279(1):354-60. PubMed ID: 11145916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
